China Universal Asset Management Co., Ltd. Vaxcyte, Inc. Transaction History
China Universal Asset Management Co., Ltd.
- $1.03 Billion
- Q4 2024
A detailed history of China Universal Asset Management Co., Ltd. transactions in Vaxcyte, Inc. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 26,428 shares of PCVX stock, worth $2.11 Million. This represents 0.21% of its overall portfolio holdings.
Number of Shares
26,428
Previous 21,466
23.12%
Holding current value
$2.11 Million
Previous $2.45 Million
11.71%
% of portfolio
0.21%
Previous 0.27%
Shares
15 transactions
Others Institutions Holding PCVX
# of Institutions
349Shares Held
130MCall Options Held
539KPut Options Held
253K-
Vanguard Group Inc Valley Forge, PA12MShares$954 Million0.02% of portfolio
-
Janus Henderson Group PLC London, X010.6MShares$843 Million0.46% of portfolio
-
Black Rock Inc. New York, NY9.94MShares$793 Million0.02% of portfolio
-
Ra Capital Management, L.P. Boston, MA8.69MShares$693 Million11.52% of portfolio
-
Capital Research Global Investors Los Angeles, CA6.21MShares$495 Million0.11% of portfolio
About Vaxcyte, Inc.
- Ticker PCVX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,315,100
- Market Cap $4.73B
- Description
- Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company a...